Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05900609
Other study ID # NL83652.028.23
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date May 22, 2023
Est. completion date March 5, 2024

Study information

Verified date September 2023
Source VU University of Amsterdam
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Within the GEEF om je buik study the effect of 8 weeks intervention with either a diet rich in fiber or fermented food on the gut microbiota will be investigated.


Description:

This study is a randomized controlled trial (RCT) with three intervention groups (high dietary fiber group (HDF), high fermented foods group (HFF), and a control group (CG)). The total duration of the study is 5 months and consists of an 8-week intervention ( 2-week ramp up period with dietary guidelines, followed by 6-week period with dietary guidelines + additional consumption of study products) and a follow-up after 3 months. In total 147 subjects will be included.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 146
Est. completion date March 5, 2024
Est. primary completion date November 26, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Men and Women, aged =18 - =70 years; - Being able to read and speak Dutch; - Willing to keep a stable dietary pattern throughout the study, apart from the dietary advice in the study; - Having a smartphone compatible with the Lifedata or PocketQ app to fill out the daily questionnaires. Exclusion Criteria: - Having a disease or medical condition which can influence the study results such as diabetes, cancer, diagnosed irritable bowel syndrome, renal disease, liver enzyme abnormality, malignant neoplasm, or a history of inflammatory diseases (such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease); - Having a history of intestinal surgery that might interfere with study outcomes (this does not include an appendectomy or cholecystectomy); - Average dietary fiber intake of =18 gram (women) or =22 gram (men) per day, according to the fiber screen questionnaire (see F1 questionnaires); - More than 3 servings of fermented foods per day as assessed with the fermented food frequency questionnaire (see F1 questionnaires); - Having a Body Mass Index (BMI) of = 30 kg/m2 (self-reported); - Currently following a strict diet and unwilling or unable to change; for example, a gluten free diet or a "crash diet" using meal substitutes; - Specific food allergies that interfere with dietary intervention (for example, gluten, lactose, etc); - Use of prebiotics, probiotics and/or synbiotics (this should be stopped 4 weeks before the start of the study) and use of fiber supplements; - Use of antibiotic treatment less than 3 months before start of the study and/or use of antibiotics during the study; - Use of medication that can interfere with the study outcomes, as judged by the medical supervisor; - Alcoholic use of =14 (women) or =28 (men) glasses of alcoholic beverages per week; - Use of soft or hard drugs (should be stopped at least 4 weeks before start of the study); - Being pregnant or lactating; - Participation in another clinical trial at the same time; - Student or employee working at either Food, Health and Consumer Research from Wageningen Food and Biobased Research, Microbiology at VU, the MLDS, at WholeFiber, Keep Food Simple or at Cidrani; - Unable to follow or comply to study rules.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
WholeFiber
WholeFiberTM is a product with high levels of prebiotic dietary fibers (~85%) mainly consisting of inulin, and some pectin, hemi-cellulose and cellulose that is derived from the root vegetable, chicory roots. Fiber guidelines: Subjects receive a booklet with recipes high in fiber. Subjects are recommended to use 2 recipes per day + a snack. Estimated average intake via the recipes in the recipe booklet is 24 grams/day. General guidelines on nutrition and microbiome: Subjects receive a link to a website with general recommendations to positively alter the gut microbiome (website Voedingscentrum and Dutch Digestive Foundation).
Kombucha
The kombucha is produced by a minimum three-month long fermentation process. It is a live fermented herbal drink essence, without refined sugar, and an unpasteurized, organic product. Fermented food guidelines: Study participants in the fermented foods arm are asked to use 3 additional servings of fermented food per day, using the fermented food list / recipe booklet. General guidelines on nutrition and microbiome: Subjects receive a link to a website with general recommendations to positively alter the gut microbiome (website Voedingscentrum and Dutch Digestive Foundation).
Maltodextrin DE19/21
Maltodextrin DE19/21 is a digestible carbohydrate, that is completely digested and does not reach the colon, which makes it a suitable placebo dietary compound and the reason why it is frequently used in comparable studies. General guidelines on nutrition and microbiome: Subjects receive a link to a website with general recommendations to positively alter the gut microbiome (website Voedingscentrum and Dutch Digestive Foundation).

Locations

Country Name City State
Netherlands Stichting Wageningen Research Wageningen Gelderland

Sponsors (6)

Lead Sponsor Collaborator
VU University of Amsterdam Cidrani, Keep Food Simple, Maag Lever Darm Stichting, Wageningen University and Research, WholeFiber

Country where clinical trial is conducted

Netherlands, 

References & Publications (4)

David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ, Turnbaugh PJ. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014 Jan 23;505(7484):559-63. do — View Citation

Myhrstad MCW, Tunsjo H, Charnock C, Telle-Hansen VH. Dietary Fiber, Gut Microbiota, and Metabolic Regulation-Current Status in Human Randomized Trials. Nutrients. 2020 Mar 23;12(3):859. doi: 10.3390/nu12030859. — View Citation

Stiemsma LT, Nakamura RE, Nguyen JG, Michels KB. Does Consumption of Fermented Foods Modify the Human Gut Microbiota? J Nutr. 2020 Jul 1;150(7):1680-1692. doi: 10.1093/jn/nxaa077. — View Citation

Wastyk HC, Fragiadakis GK, Perelman D, Dahan D, Merrill BD, Yu FB, Topf M, Gonzalez CG, Van Treuren W, Han S, Robinson JL, Elias JE, Sonnenburg ED, Gardner CD, Sonnenburg JL. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021 Aug 5;184 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Body Mass Index (BMI) Weight and height will be combined to report BMI in kg/m^2 Baseline (week 0)
Other Body Mass Index (BMI) Weight and height will be combined to report BMI in kg/m^2 End ramp-up (week 2)
Other Body Mass Index (BMI) Weight and height will be combined to report BMI in kg/m^2 End intervention (week 8)
Other Body Mass Index (BMI) Weight and height will be combined to report BMI in kg/m^2 End follow-up (5 months)
Primary Microbiota diversity Microbioal richness (ASV) using 16s rRNA Baseline (week 0)
Primary Microbiota diversity Microbioal richness (ASV) using 16s rRNA End ramp-up (week 2)
Primary Microbiota diversity Microbioal richness (ASV) using 16s rRNA End intervention (week 8)
Secondary Gut microbiota composition 16s rRNA Baseline (week 0)
Secondary Gut microbiota composition 16s rRNA End ramp-up (week 2)
Secondary Gut microbiota composition 16s rRNA End intervention (week 8)
Secondary Carbohydrate Active Enzymes (CAZymes) Relative abundance of CAZymes using shotgun metagenomic sequencing Baseline (week 0)
Secondary Carbohydrate Active Enzymes (CAZymes) Relative abundance of CAZymes using shotgun metagenomic sequencing End ramp-up (week 2)
Secondary Carbohydrate Active Enzymes (CAZymes) Relative abundance of CAZymes using shotgun metagenomic sequencing End intervention (week 8)
Secondary 92 inflammatory serum proteins 92 protein biomarkers proteins associated with inflammatory and immune response processes measured in dried blood spots using the Olink target 96 panels. Expressed as normalized protein expression (NPX). Baseline (week 0)
Secondary 92 inflammatory serum proteins 92 protein biomarkers proteins associated with inflammatory and immune response processes measured in dried blood spots using the Olink target 96 panels. Expressed as normalized protein expression (NPX). End ramp-up (week 2)
Secondary 92 inflammatory serum proteins 92 protein biomarkers proteins associated with inflammatory and immune response processes measured in dried blood spots using the Olink target 96 panels. Expressed as normalized protein expression (NPX). End intervention (week 8)
Secondary Dietary intake Average intake of fiber, fermented foods and macronutrients using the Traqq app Baseline (week 0)
Secondary Dietary intake Average intake of fiber, fermented foods and macronutrients using the Traqq app End ramp-up (week 2)
Secondary Dietary intake Average intake of fiber, fermented foods and macronutrients using the Traqq app End intervention (week 8)
Secondary Dietary intake Average intake of fiber, fermented foods and macronutrients using the Traqq app End follow-up (5 months)
Secondary Gastrointestinal complaints Likert-point scale (scores 0 - 10), for bloating, flatulence and abdominal pain. A higher score means more bloating, flatulence and abdominal pain. Daily during intervention (week 0 - week 8)
Secondary Stool frequency Frequency of bowel movement per day Daily during intervention (week 0 - week 8)
Secondary Stool consistency Consistency per stool, based on Bristol Stool Score (type 1 -7). Scores 1-7. A higher score means more loose / watery stool. Daily during intervention (week 0 - week 8)
Secondary Abundance of Prevotella Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). Baseline (week 0)
Secondary Abundance of Prevotella Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). End ramp-up (week 2)
Secondary Abundance of Prevotella Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). End intervention (week 8)
Secondary Abundance of Bacteroides Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). Baseline (week 0)
Secondary Abundance of Bacteroides Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). End ramp-up (week 2)
Secondary Abundance of Bacteroides Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). End intervention (week 8)
Secondary Ratio of Prevotella/Bacteroides Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). Baseline (week 0)
Secondary Ratio of Prevotella/Bacteroides Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). End ramp-up (week 2)
Secondary Ratio of Prevotella/Bacteroides Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). End intervention (week 8)
Secondary Microbial alpha diversity Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). Baseline (week 0)
Secondary Microbial alpha diversity Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). End ramp-up (week 2)
Secondary Microbial alpha diversity Based on a faecal smear image, using MicrobeLink tool from HORAIZON (AI, machine learning). End intervention (week 8)
Secondary Transit time Using blue dye method (two blue muffins) Baseline (week 0)
Secondary Transit time Using blue dye method (two blue muffins) End ramp-up (week 2)
Secondary Transit time Using blue dye method (two blue muffins) End intervention (week 8)
Secondary Sleep quality Athens insomnia scale. Score range: 0-28 points. Higher score means worse outcome. Baseline (week 0)
Secondary Sleep quality Athens insomnia scale. Score range: 0-28 points. Higher score indicates worse sleep quality. End ramp-up (week 2)
Secondary Sleep quality Athens insomnia scale. Score range: 0-28 points. Higher score indicates worse sleep quality. End intervention (week 8)
Secondary Sleep quality Athens insomnia scale. Score range: 0-28 points. Higher score indicates worse sleep quality. End follow-up (5 months)
Secondary Digestion associated Quality of Life Digestion associated Quality of Life (DQLQ) questionnaire. Score range: 0-9. Higher score indicates worse digestion associated quality of life. Baseline (week 0)
Secondary Digestion associated Quality of Life Digestion associated Quality of Life (DQLQ) questionnaire. Score range: 0-9. Higher score indicates worse digestion associated quality of life. End ramp-up (week 2)
Secondary Digestion associated Quality of Life Digestion associated Quality of Life (DQLQ) questionnaire. Score range: 0-9. Higher score indicates worse digestion associated quality of life. End intervention (week 8)
Secondary Digestion associated Quality of Life Digestion associated Quality of Life (DQLQ) questionnaire. Score range: 0-9. Higher score indicates worse digestion associated quality of life. End follow-up (5 months)
Secondary Well-being World Health Organisation (WHO)-Five Well-Being Index (WHO-5) questionnaire. Raw score ranges from 0-25. Final score is calculated by multiplying the raw score by 4. Final score range 0-100. Higher score indicates better well-being. Baseline (week 0)
Secondary Well-being World Health Organisation (WHO)-Five Well-Being Index (WHO-5) questionnaire. Raw score ranges from 0-25. Final score is calculated by multiplying the raw score by 4. Final score range 0-100. Higher score indicates better well-being. End ramp-up (week 2)
Secondary Well-being World Health Organisation (WHO)-Five Well-Being Index (WHO-5) questionnaire. Raw score ranges from 0-25. Final score is calculated by multiplying the raw score by 4. Final score range 0-100. Higher score indicates better well-being. End intervention (week 8)
Secondary Well-being World Health Organisation (WHO)-Five Well-Being Index (WHO-5) questionnaire. Raw score ranges from 0-25. Final score is calculated by multiplying the raw score by 4. Final score range 0-100. Higher score indicates better well-being. End follow-up (5 months)
Secondary Subjective health (perception and awareness) A 2-item questionnaire, which assesses how healthy participants perceive their own health and diet. Score range: 2 - 14, higher scores mean a higher subjective health Baseline (week 0)
Secondary Subjective health (perception and awareness) A 2-item questionnaire, which assesses how healthy participants perceive their own health and diet. Score range: 2 - 14, higher scores mean a higher subjective health End intervention (week 8)
Secondary Subjective health (perception and awareness) A 2-item questionnaire, which assesses how healthy participants perceive their own health and diet. Score range: 2 - 14, higher scores mean a higher subjective health End follow-up (5 months)
Secondary Intention to stay healthy (perception + awareness) A 3-item questionnaire, which assesses the extent to which participants have the intention to eat healthy. Score range: 3 - 21, higher scores mean more intention to stay healthy Baseline (week 0)
Secondary Intention to stay healthy (perception + awareness) A 3-item questionnaire, which assesses the extent to which participants have the intention to eat healthy. Score range: 3 - 21, higher scores mean more intention to stay healthy End intervention (week 8)
Secondary Intention to stay healthy (perception + awareness) A 3-item questionnaire, which assesses the extent to which participants have the intention to eat healthy. Score range: 3 - 21, higher scores mean more intention to stay healthy End follow-up (5 months)
Secondary Dietary intrinsic motivation (perception + awareness) A validated 6-item questionnaire, which assesses whether someone's motivation to eat healthy comes from within a person. Score range: 6 - 42, higher scores mean a higher intrinsic motivation. Baseline (week 0)
Secondary Dietary intrinsic motivation (perception + awareness) A validated 6-item questionnaire, which assesses whether someone's motivation to eat healthy comes from within a person. Score range: 6 - 42, higher scores mean a higher intrinsic motivation. End intervention (week 8)
Secondary Dietary intrinsic motivation (perception + awareness) A validated 6-item questionnaire, which assesses whether someone's motivation to eat healthy comes from within a person. Score range: 6 - 42, higher scores mean a higher intrinsic motivation. End follow-up (5 months)
Secondary Dietary self-efficacy (perception + awareness) A validated 8-item questionnaire, which assesses the extent to which one feels capable of eating healthy. Score range: 8 - 49, higher scores mean a higher self-efficacy Baseline (week 0)
Secondary Dietary self-efficacy (perception + awareness) A validated 8-item questionnaire, which assesses the extent to which one feels capable of eating healthy. Score range: 8 - 49, higher scores mean a higher self-efficacy End intervention (week 8)
Secondary Dietary self-efficacy (perception + awareness) A validated 8-item questionnaire, which assesses the extent to which one feels capable of eating healthy. Score range: 8 - 49, higher scores mean a higher self-efficacy End follow-up (5 months)
Secondary Self-regulation (perception + awareness) A 5-item questionnaire, which assesses the ability to plan and monitor actions. Score range: 5 - 35, higher scores mean a higher self-regulation Baseline (week 0)
Secondary Self-regulation (perception + awareness) A 5-item questionnaire, which assesses the ability to plan and monitor actions. Score range: 5 - 35, higher scores mean a higher self-regulation End intervention (week 8)
Secondary Self-regulation (perception + awareness) A 5-item questionnaire, which assesses the ability to plan and monitor actions. Score range: 5 - 35, higher scores mean a higher self-regulation End follow-up (5 months)
Secondary Subjective knowledge (perception + awareness) A validated 5-item questionnaire, which assesses how knowledgeable someone feels about nutrition and gut microbiota. Score range: 5 - 35, higher scores mean a higher subjective knowledge Baseline (week 0)
Secondary Subjective knowledge (perception + awareness) A validated 5-item questionnaire, which assesses how knowledgeable someone feels about nutrition and gut microbiota. Score range: 5 - 35, higher scores mean a higher subjective knowledge End intervention (week 8)
Secondary Subjective knowledge (perception + awareness) A validated 5-item questionnaire, which assesses how knowledgeable someone feels about nutrition and gut microbiota. Score range: 5 - 35, higher scores mean a higher subjective knowledge End follow-up (5 months)
See also
  Status Clinical Trial Phase
Recruiting NCT05414994 - Assessment of the Ocular Microbiome in Health and Disease
Completed NCT04769882 - Er:YAG Laser Effects on Microbial Population in Conservative Dentistry N/A
Completed NCT04766528 - Effect of Diet on the Microbiota / Endoccanabinoidome Axis in Response to Physical Activity N/A
Completed NCT03720314 - Microbiota Profiling in IBS
Completed NCT04122612 - Shaping Microbiome in the First 1,000 Days of Life
Not yet recruiting NCT05405634 - Microbiota in Chronic Anal Fissure and Its Association With Prognosis
Not yet recruiting NCT04895774 - Ex Vivo Study of the Mechanism of Action of Active Ingredients on the Intestinal Microbiota
Recruiting NCT05992688 - The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time) N/A
Recruiting NCT05502380 - Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery Phase 3
Completed NCT05175833 - Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19 Phase 2
Recruiting NCT04836910 - Microbiome and Polycystic Ovaries
Recruiting NCT05603650 - Effects of Mouthrinses on the Microbiome of the Oral Cavity and GI Tract N/A
Completed NCT05575050 - Impact of Teeth Brushing in Ventilated COVID-19 Patients. N/A
Completed NCT04991818 - MSC - OneBiome UX Pilot Study N/A
Completed NCT04374955 - The Effect of Probiotic Added to Maternal Diet on Infantile Colic and Intestinal Microbiota Content N/A
Recruiting NCT04140747 - Transfer of Strictly Anaerobe Microbes From Mother to Child
Recruiting NCT04111471 - The Use of A Prebiotic to Promote a Healthy Gut Microbiome in Pediatric Stem Cell Transplant Recipients N/A
Suspended NCT03220282 - The Milk, Growth and Microbiota Study N/A
Completed NCT03422562 - Probiotics and Intestinal Microbiome in Preterm Infants Phase 3
Recruiting NCT05695196 - Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant Phase 1